Ambrx
Barbara Potts is a highly experienced patent agent with a robust background in chemistry and intellectual property management. Currently serving as a Patent Agent at Ambrx since January 2022, Barbara has previously held roles such as Patent Strategy Manager at Ecovative Design and Patent Agent positions at Progenity, Inc. and Allergan. With a career beginning in pharmaceutical research, Barbara was VP of Chemistry & Oncology Research at Nereus Pharmaceuticals and a Senior Scientist at Agouron/Pfizer. Academic contributions include serving as an Adjunct Professor at California State University San Marcos in the Department of Chemistry & Biochemistry. Barbara holds a Ph.D. in Organic Chemistry from UC San Diego and is registered with the USPTO (Registration Number 72237).
This person is not in any teams
Ambrx
Ambrx, Inc. is a biopharmaceutical company with a mission to deliver breakthrough protein therapeutics. Ambrx is based on a fundamental advance in protein biosynthesis that enables the company to genetically engineer proteins with new amino acid building blocks beyond the common twenty, enabling the biosynthesis of proteins with new physical, chemical and pharmacological properties.